Medicare Enrolled
Dr. Carlos Taboada, MD
Medical Oncology · Plano, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Taboada from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Taboada?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Taboada
Dr. Carlos Taboada is a medical oncology specialist in Plano, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Taboada performed 46,737 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Taboada received a total of $5,998 from 57 pharmaceutical and/or device companies across 146 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Taboada is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 22% volume in TX
$5,998 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗46,737
Medicare services
Top 22% in TX for medical oncology
Not available
Unique patients (not deduplicated)
$12
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron sucrose injection (Venofer) An injection of iron sucrose used to replenish iron levels in the body. |
14,400 | $0 | $2 |
| Darbepoetin injection (Aranesp) for anemia An injection of darbepoetin alfa used for non-end-stage renal disease purposes. |
8,805 | $2 | $20 |
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
6,415 | $0 | $3 |
| Pembrolizumab injection (Keytruda) | 4,200 | $43 | $136 |
| Paclitaxel chemotherapy injection | 1,864 | $0 | $8 |
| Immune globulin infusion (Octagam) This procedure involves the administration of immune globulin medication directly into a vein. It is provided in a non-lyophilized liquid form. |
1,710 | $34 | $235 |
| Denosumab injection (Prolia/Xgeva) | 1,260 | $18 | $66 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,006 | $0 | $1 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
903 | $8 | $20 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
824 | $8 | $36 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
717 | $10 | $64 |
| Bortezomib injection, 0.1 mg Administration of a 0.1 mg dose of bortezomib medication via injection. |
665 | $4 | $116 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
575 | $90 | $368 |
| Injection, granisetron hydrochloride, 100 mcg | 560 | $0 | $24 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
250 | $12 | $108 |
| Anti-nausea injection (Aloxi/palonosetron) | 190 | $1 | $114 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
165 | $95 | $707 |
| Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 | 131 | $20 | $128 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
117 | $48 | $313 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
103 | $13 | $60 |
| Iron level test | 101 | $6 | $27 |
| Iron binding capacity test A blood test that measures the amount of iron in the blood and the blood's ability to bind and transport iron. |
101 | $9 | $35 |
| Manual white blood cell count A laboratory test that involves examining a sample under a microscope to manually count the number of white blood cells present. |
96 | $4 | $22 |
| Complete blood count (CBC), automated An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood. |
96 | $6 | $34 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
94 | $11 | $96 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 80 | $88 | $657 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
78 | $2 | $300 |
| Nuclear medicine scan from skull base to mid-thigh with CT A nuclear medicine imaging study covering the area from the base of the skull to the middle of the thighs, performed alongside a CT scan. |
75 | $1,101 | $4,802 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
73 | $56 | $250 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
73 | $61 | $247 |
| Lactate dehydrogenase (LDH) level test A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease. |
71 | $6 | $31 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
64 | $2 | $19 |
| CT scan of chest with contrast A computed tomography scan of the chest using a contrast dye to enhance the visibility of internal structures. |
63 | $47 | $821 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
61 | $135 | $496 |
| CT scan of abdomen and pelvis with contrast A CT scan that uses dye to create detailed images of the abdomen and pelvis. This imaging test helps doctors examine internal organs and structures in these areas. |
58 | $170 | $1,067 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
58 | $1 | $7 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
55 | $21 | $161 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
51 | $49 | $344 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
50 | $22 | $157 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
50 | $1 | $8 |
| Reticulated platelet measurement A blood test that measures the level of young, newly formed platelets in the body. |
49 | $35 | $143 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
48 | $124 | $565 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
44 | $55 | $211 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
40 | $15 | $100 |
| Carcinoembryonic antigen (CEA) level test A blood test that measures the level of carcinoembryonic antigen (CEA) protein. This test is used to monitor certain types of cancer. |
39 | $19 | $99 |
| CT scan of chest, without contrast A computed tomography scan of the chest area that uses X-rays to create detailed images without the use of contrast dye. |
29 | $41 | $686 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
28 | $10 | $75 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
27 | $24 | $256 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
23 | $91 | $357 |
| Concurrent intravenous infusion Administration of medication or fluid into a vein for therapy, prevention, or diagnosis while another infusion is being given. |
22 | $15 | $94 |
| Manual urinalysis with microscopic examination A urine test performed manually without automated equipment. The sample is examined under a microscope to check for abnormalities. |
20 | $4 | $26 |
| Injection, fosnetupitant 235 mg and palonosetron 0.25 mg | 18 | $333 | $1,722 |
| CT scan of abdomen and pelvis, without contrast A computed tomography scan that creates detailed images of the abdominal and pelvic organs. The procedure is performed without the use of intravenous contrast dye. |
16 | $62 | $560 |
| Venipuncture for blood collection A procedure to draw blood from a vein for medical testing or analysis. |
14 | $72 | $264 |
| Automated red blood cell count with calculations A blood test that automatically counts red blood cells and performs additional calculations to assess blood health. |
12 | $5 | $26 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
4.8% high complexity
86.0% medium
9.2% routine
Industry Payment Transparency
Open Payments through 2024 ↗$5,998
Total received (2018-2024)
Avg $857/year across 7 years
Top 44% in TX for medical oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
57
Companies
146
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$896
2023
$1,164
2022
$1,513
2021
$685
2020
$316
2019
$899
2018
$526
Payments by company (2024)
Novartis Pharmaceuticals Corporation
$157
Pacira Pharmaceuticals Incorporated
$117
Sanara MedTech Inc.
$108
Janssen Biotech, Inc.
$100
Merck Sharp & Dohme LLC
$62
Gilead Sciences, Inc.
$52
Tempus AI, Inc
$47
GlaxoSmithKline, LLC.
$41
GENZYME CORPORATION
$37
AstraZeneca Pharmaceuticals LP
$37
Daiichi Sankyo Inc.
$27
Blueprint Medicines Corporation
$27
Celgene Corporation
$26
E.R. Squibb & Sons, L.L.C.
$20
Agios Pharmaceuticals, Inc.
$19
ABBVIE INC.
$19
Top 3 companies account for 42.7% of 2024 payments
All-time payments by company (2018-2024) ›
Celgene Corporation
$626
Ethicon US, LLC
$603
Novartis Pharmaceuticals Corporation
$360
Exelixis Inc.
$282
Pacira Pharmaceuticals Incorporated
$242
Gilead Sciences, Inc.
$200
Allergan Inc.
$154
Sirtex Medical Inc
$152
Janssen Biotech, Inc.
$151
Biom'Up France SAS
$149
TELA Bio, Inc.
$146
DAVOL INC.
$136
Covidien LP
$134
Novo Nordisk Inc
$133
Pharmacyclics LLC, An AbbVie Company
$131
AstraZeneca Pharmaceuticals LP
$130
Axonics, Inc.
$127
Synergy Pharmaceuticals Inc
$125
Medtronic USA, Inc.
$125
Merck Sharp & Dohme LLC
$113
Integra LifeSciences Corporation
$111
Dova Pharmaceuticals
$108
Sanara MedTech Inc.
$108
Trevena, Inc.
$100
Fresenius Kabi USA, LLC
$100
RedHill Biopharma Inc.
$98
AbbVie, Inc.
$95
CTI BioPharma Corp.
$92
Daiichi Sankyo Inc.
$89
PharmaEssentia USA Corporation
$69
GlaxoSmithKline, LLC.
$67
E.R. Squibb & Sons, L.L.C.
$63
GENZYME CORPORATION
$62
Seagen Inc.
$47
Tempus AI, Inc
$47
Incyte Corporation
$46
ABBVIE INC.
$42
Puma Biotechnology, Inc.
$35
Ferring Pharmaceuticals Inc.
$35
PFIZER INC.
$28
Kite Pharma, Inc.
$28
Blueprint Medicines Corporation
$27
EISAI INC.
$26
AbbVie Inc.
$25
Acrotech Biopharma LLC
$24
Amgen Inc.
$23
SOBI, INC
$22
GE HealthCare
$21
Genentech USA, Inc.
$19
Agios Pharmaceuticals, Inc.
$19
Karyopharm Therapeutics Inc.
$19
ADC Therapeutics America, Inc.
$17
Apellis Pharmaceuticals, Inc.
$15
Ipsen Biopharmaceuticals, Inc
$15
EUSA Pharma (US) LLC
$14
EMD Serono, Inc.
$13
Siemens Medical Solutions USA, Inc.
$12
Top 3 companies account for 26.5% of all-time payments
Associated products mentioned in payments ›
AYVAKIT · Aemcolo · Axonics r-SNM System · BELEODAQ · BESREMI · BLENREP · CABLIVI · CLENPIQ · CODMAN CERTAS · Cabometyx · CellerateRx · DARZALEX · Doptelet · ECHELON ENDOPATH · ENHERTU · EPKINLY · Echelon Flex · Echelon; Endopath · Empaveli · Enhertu · Exparel · Fabhalta · HEMOBLAST BELLOWS · IBRANCE · IMBRUVICA · IMFINZI · IMMULITE Immunoassay Reagents/Test Kit/Clinical Utilization · INTERSTIM ICON · Imbruvica · JAKAFI · JEVTANA · KEYTRUDA · KISQALI · LUTATHERA · LYNPARZA · Lenvima · MEKINIST · MONJUVI · Nplate · OJJAARA · OLINVYK · ONUREG · OPDIVO · OPDUALAG · Ovitex · Ozempic · PADCEV · PHASIX · PIQRAY · PLUVICTO · Pomalyst · RYBREVANT · SCEMBLIX · SIR-Spheres Microspheres · SOMATULINE DEPOT · STRATTICE · Skyrizi · Smoflipid · Sonicision · Sylvant · TABRECTA · TECVAYLI · Tecentriq · Trodelvy · Trulance · VENCLEXTA · Vonjo · XPOVIO
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Medical oncologists in nearby ZIP areas
75
County median income
$117,588
Nearest hospital to ZIP centroid (approximate)
MEDICAL CITY PLANO
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Taboada is a mixed practice specialist, with above-average Medicare volume (top 22% in TX), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Taboada experienced with iron sucrose injection (venofer)?
Based on Medicare claims data, Dr. Taboada performed 14,400 iron sucrose injection (venofer) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Taboada receive payments from pharmaceutical companies?
Yes. Dr. Taboada received a total of $5,998 from 57 companies across 146 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Taboada's costs compare to other medical oncologists in Plano?
Dr. Taboada's average Medicare payment per service is $12. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Taboada) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Medical Oncologists in Plano
Browse medical oncologists in Plano ranked by procedure volume and transparency data.
Highest volume
Top Medical Oncologists in TX
Medical oncologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Medical Oncologists in TX
Which TX medical oncologists receive the most from drug and device companies.
By company
Celgene Corporation Payments to Doctors
See all physicians who received payments from Celgene Corporation.
By company
Ethicon US, LLC Payments to Doctors
See all physicians who received payments from Ethicon US, LLC.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology